$ATYR
aTyr Pharma Inc

2016 Q1 Form 10-K Financial Statement

#000156459016015652 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.120M $3.810M $1.690M
YoY Change 76.82% 125.44% 40.83%
% of Gross Profit
Research & Development $12.00M $12.67M $4.340M
YoY Change 82.01% 191.94% 5.6%
% of Gross Profit
Depreciation & Amortization $233.0K $230.0K $210.0K
YoY Change 11.48% 9.52% 10.53%
% of Gross Profit
Operating Expenses $16.12M $16.48M $6.030M
YoY Change 80.62% 173.35% 13.56%
Operating Profit -$16.12M
YoY Change 80.62%
Interest Expense -$40.00K -$260.0K
YoY Change -84.62% 100.0%
% of Operating Profit
Other Income/Expense, Net $28.00K
YoY Change -118.79%
Pretax Income -$16.09M -$16.49M -$6.040M
YoY Change 77.4% 173.01% 11.03%
Income Tax
% Of Pretax Income
Net Earnings -$16.09M -$16.49M -$6.038M
YoY Change 77.35% 173.15% 10.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$9.521M -$9.700M -$3.752M
COMMON SHARES
Basic Shares Outstanding 23.68M 23.65M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.00M $95.54M $15.90M
YoY Change 57.8% 500.85%
Cash & Equivalents $54.10M $53.03M $13.90M
Short-Term Investments $31.90M $42.51M $2.000M
Other Short-Term Assets $1.600M $2.400M $700.0K
YoY Change 128.57% 242.86%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $87.60M $97.95M $16.51M
YoY Change 58.78% 493.31%
LONG-TERM ASSETS
Property, Plant & Equipment $1.800M $1.793M $1.925M
YoY Change -2.12% -6.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.60M $29.80M
YoY Change
Other Assets $100.0K $118.0K $2.210M
YoY Change -96.55% -94.66%
Total Long-Term Assets $27.50M $31.73M $4.135M
YoY Change 480.66% 667.23%
TOTAL ASSETS
Total Short-Term Assets $87.60M $97.95M $16.51M
Total Long-Term Assets $27.50M $31.73M $4.135M
Total Assets $115.1M $129.7M $20.64M
YoY Change 92.14% 528.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.900M $3.872M $1.433M
YoY Change 86.24% 170.2%
Accrued Expenses $3.600M $4.595M $2.932M
YoY Change 36.11% 56.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.400M $3.366M $5.100M
YoY Change -34.62% -34.0%
Total Short-Term Liabilities $13.19M $12.15M $10.11M
YoY Change 14.26% 20.12%
LONG-TERM LIABILITIES
Long-Term Debt $900.0K $1.776M $5.100M
YoY Change -79.07% -65.18%
Other Long-Term Liabilities $557.0K $571.0K $335.0K
YoY Change 46.58% 70.45%
Total Long-Term Liabilities $557.0K $2.347M $335.0K
YoY Change 46.58% 600.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.19M $12.15M $10.11M
Total Long-Term Liabilities $557.0K $2.347M $335.0K
Total Liabilities $13.75M $14.50M $10.45M
YoY Change 15.29% 38.73%
SHAREHOLDERS EQUITY
Retained Earnings -$174.2M -$158.1M -$110.2M
YoY Change 46.12% 43.55%
Common Stock $274.7M $273.3M $19.21M
YoY Change 1194.6% 1322.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.4M $115.1M -$91.01M
YoY Change
Total Liabilities & Shareholders Equity $115.1M $129.7M $20.64M
YoY Change 92.18% 528.15%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2014 Q4
OPERATING ACTIVITIES
Net Income -$16.09M -$16.49M -$6.038M
YoY Change 77.35% 173.15% 10.99%
Depreciation, Depletion And Amortization $233.0K $230.0K $210.0K
YoY Change 11.48% 9.52% 10.53%
Cash From Operating Activities -$12.49M -$9.840M -$5.800M
YoY Change 98.57% 69.66% 34.57%
INVESTING ACTIVITIES
Capital Expenditures $314.0K -$110.0K $0.00
YoY Change 155.28% -100.0%
Acquisitions
YoY Change
Other Investing Activities $14.71M $4.020M $2.750M
YoY Change 654.36% 46.18%
Cash From Investing Activities $14.39M $3.910M $2.750M
YoY Change 686.34% 42.18% -1048.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.00K
YoY Change -84.06%
Debt Paid & Issued, Net $838.0K
YoY Change
Cash From Financing Activities -830.0K -1.090M -1.790M
YoY Change -101.84% -39.11% -18000.0%
NET CHANGE
Cash From Operating Activities -12.49M -9.840M -5.800M
Cash From Investing Activities 14.39M 3.910M 2.750M
Cash From Financing Activities -830.0K -1.090M -1.790M
Net Change In Cash 1.070M -7.020M -4.840M
YoY Change -97.37% 45.04% 5.45%
FREE CASH FLOW
Cash From Operating Activities -$12.49M -$9.840M -$5.800M
Capital Expenditures $314.0K -$110.0K $0.00
Free Cash Flow -$12.80M -$9.730M -$5.800M
YoY Change 99.66% 67.76% 44.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1925000
CY2015Q2 dei Entity Public Float
EntityPublicFloat
282395534
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13899000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
315000
CY2015 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
42510000
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
1954000
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
29814000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
295000
CY2015Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3366000
CY2014Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3134000
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2000000
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
319000
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
445000
CY2015Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
1776000
CY2014Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
5142000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
571000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
335000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
95619000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
24000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
273321000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19209000
CY2014Q4 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
69000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-171000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-158124000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110151000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
115050000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-91010000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129675000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20644000
CY2015Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2014Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
95619000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13832000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-47616000
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-386000
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-19542000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95500000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23670079
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
909880
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23670079
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
909880
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
762761
CY2014 us-gaap Operating Expenses
OperatingExpenses
23554000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5710000
CY2013 us-gaap Operating Expenses
OperatingExpenses
19542000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4595000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2932000
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23677303
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1433000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1793000
CY2015Q4 us-gaap Assets
Assets
129675000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53025000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
656000
CY2014Q4 us-gaap Assets
Assets
20644000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2415000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
97950000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
16509000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2210000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3872000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12148000
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4856000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
535000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-23554000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
666000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1043000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3944000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-207000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-47973000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-171000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.03
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-29.69
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34504000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16777000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13112000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000
CY2015 us-gaap Operating Expenses
OperatingExpenses
47616000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48144000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.18
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
47000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-64554000
CY2013 life Increase Decrease To Additional Paid In Capital Changes To Share Repurchase Liability
IncreaseDecreaseToAdditionalPaidInCapitalChangesToShareRepurchaseLiability
-3000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
155000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10113000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
130000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
8922000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
10898000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
11313000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
16483000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-9071000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-11080000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-11329000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-16493000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.39
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-832000
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-444000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-29000
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-36000
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
28000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-357000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-796000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-472000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-24350000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-20014000
CY2015 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15000
CY2014 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
416000
CY2013 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1637000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47988000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24766000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21651000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-28.39
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15838353
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
834221
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24350000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20014000
CY2013 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
2431000
CY2013 life Temporary Stock Issuance Costs
TemporaryStockIssuanceCosts
65000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77000
CY2013 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1637000
CY2013 life Capital Contribution Related To Reversal Of Historical Accretion Of Redeemable Convertible Preferred Stock
CapitalContributionRelatedToReversalOfHistoricalAccretionOfRedeemableConvertiblePreferredStock
17528000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-66082000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
72000
CY2014 life Increase Decrease To Additional Paid In Capital Changes To Share Repurchase Liability
IncreaseDecreaseToAdditionalPaidInCapitalChangesToShareRepurchaseLiability
13000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1791000
CY2014 life Changes In Equity Dissolution Of Affiliates
ChangesInEquityDissolutionOfAffiliates
-2038000
CY2014 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
416000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
171284000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75903000
CY2015 life Stockholders Equity Repayment Of Stockholder Note Receivable
StockholdersEquityRepaymentOfStockholderNoteReceivable
60000
CY2015 life Reclassification Of Convertible Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapital
290000
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1411000
CY2015 life Increase Decrease To Additional Paid In Capital Changes To Share Repurchase Liability
IncreaseDecreaseToAdditionalPaidInCapitalChangesToShareRepurchaseLiability
-120000
CY2015 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
15000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
869000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
829000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
714000
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1411000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4856000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1791000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
155000
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
297000
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
426000
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
211000
CY2015 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-789000
CY2014 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-43000
CY2015 life Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
-295000
CY2014 life Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
-277000
CY2013 life Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
-254000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-323000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1526000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36797000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1648000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-47490000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-34885000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-483000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10535000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
249000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
644000
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
109445000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22824000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17311000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
664000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.60
CY2014 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5397000
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38115000
CY2014 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3400000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-71994000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2246000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-644000
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
75648000
CY2013 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
38660000
CY2015 life Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
76902000
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
999000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
604000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
72000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
77000
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5000000
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5000000
CY2015 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
3237000
CY2014 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1561000
CY2013 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
2500000
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2000000
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
500000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
147917000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2512000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
50737000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
39126000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-22558000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
32782000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36457000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3675000
CY2015 us-gaap Interest Paid
InterestPaid
925000
CY2014 us-gaap Interest Paid
InterestPaid
415000
CY2013 us-gaap Interest Paid
InterestPaid
254000
CY2014 life Issuance Of Warrants In Connection With Long Term Debt
IssuanceOfWarrantsInConnectionWithLongTermDebt
148000
CY2013 life Issuance Of Warrants In Connection With Long Term Debt
IssuanceOfWarrantsInConnectionWithLongTermDebt
137000
CY2013 life Conversion Of Convertible Debt And Accrued Interest
ConversionOfConvertibleDebtAndAccruedInterest
9537000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
5930000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6093000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.87
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles (GAAP). The preparation of our consolidated financial statements requires us to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements and accompanying notes. The most significant estimates in our consolidated financial statements relate to the fair value of equity issuances and awards, and clinical trial and research and development expenses. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ materially from these estimates and assumptions.</p></div>
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.17%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to significant concentration of credit risk consist primarily of cash, cash equivalents and investment securities. We have established guidelines regarding diversification of investments and their maturities, which are designed to maintain principal and maximize liquidity. We maintain deposits in federally insured financial institutions in excess of federally insured limits. We have not experienced any losses in such accounts and we believe that we are not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held.</p></div>
CY2015 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
61814
CY2015 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On May 5, 2015, we filed an amendment to our amended and restated certificate of incorporation to effect a one-for-7.95413 reverse stock split of our common stock (the Reverse Stock Split). The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.
CY2015 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
7.95413
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
72300000
CY2015 life Adjustment Of Amortized Cost And Fair Value Of Investment Securities
AdjustmentOfAmortizedCostAndFairValueOfInvestmentSecurities
200000
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
61457
CY2013 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
76587
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2668613
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10873764
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10172894
CY2015 life Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
15900167
CY2014 life Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
895678
CY2013 life Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
839348
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
69327000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
171000
CY2015 life Available For Sale Securities Contractual Maturity Period
AvailableForSaleSecuritiesContractualMaturityPeriod
P2Y
CY2015Q4 life Available For Sale Securities In Unrealized Loss Positions
AvailableForSaleSecuritiesInUnrealizedLossPositions
39
CY2015 life Available For Sale Securities In Gross Unrealized Loss Position Maturities Term Maximum
AvailableForSaleSecuritiesInGrossUnrealizedLossPositionMaturitiesTermMaximum
P12M
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5541000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4888000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3748000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2963000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1710000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
684000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2885000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2248000
CY2015 life Noncancelable Operating Leases Term Of Expiration
NoncancelableOperatingLeasesTermOfExpiration
2017-05
CY2011Q4 life Lease Agreement Extended Term
LeaseAgreementExtendedTerm
P5Y
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
CY2015Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2000000
CY2015Q2 us-gaap Interest Paid
InterestPaid
500000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
610000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
231000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
841000
CY2014Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
75772871
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1514471
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1715028
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
197253
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25970
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1900000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
400000
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12700000
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4766580
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11053954
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-11085000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
406966
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2625280
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2625280
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
899931
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.29
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.78
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.37
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.83
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.83
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.91
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y7D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M21D
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6684000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6684000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5063000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.29
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.42
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-8929000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47973000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24350000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20014000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16311000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8279000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6804000
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2023000
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-634000
CY2015 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
19000
CY2014 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-321000
CY2013 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
734000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
396000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2674000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
372000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
397000
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
1070000
CY2014 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
144000
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
159000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
84000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3391000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2978000
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
3551000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
112000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
293000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-26000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13415000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13553000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4722000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48319000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34846000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21293000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24869000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20066000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13093000
CY2015Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
14181000
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
7855000
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
6684000
CY2015Q4 life Deferred Tax Assets Tax Credit Carryforwards Research And Other State
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOtherState
3565000
CY2014Q4 life Deferred Tax Assets Tax Credit Carryforwards Research And Other State
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOtherState
1368000
CY2013Q4 life Deferred Tax Assets Tax Credit Carryforwards Research And Other State
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOtherState
1171000
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
4176000
CY2014Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
4926000
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
28000
CY2015Q4 life Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
120000
CY2014Q4 life Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
260000
CY2013Q4 life Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
360000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
891000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
677000
CY2014Q3 life Number Of Variable Interest Entities
NumberOfVariableInterestEntities
6
CY2014Q4 life Recognized Intangible Assets
RecognizedIntangibleAssets
0
CY2014 life Amortization Of Intellectual Property
AmortizationOfIntellectualProperty
P15Y
CY2015 life Period Of Change In Ownership
PeriodOfChangeInOwnership
P3Y
CY2015 life Percentage Of Change In Ownership
PercentageOfChangeInOwnership
0.50
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
774000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
79000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
94000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
947000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
177000
CY2014 life Unrecognized Tax Benefits Period Increase Decrease Other
UnrecognizedTaxBenefitsPeriodIncreaseDecreaseOther
-18000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1106000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2404000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1523000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5033000
CY2015Q4 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
0
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
5363000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
6231000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
6030000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-5588000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-6631000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-6038000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.85
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.02
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.04

Files In Submission

Name View Source Status
0001564590-16-015652-index-headers.html Edgar Link pending
0001564590-16-015652-index.html Edgar Link pending
0001564590-16-015652.txt Edgar Link pending
0001564590-16-015652-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gfpoucn3dmac000001.jpg Edgar Link pending
gx5w3hu2llfz000001.jpg Edgar Link pending
gx5w3hu2llfz000002.jpg Edgar Link pending
gx5w3hu2llfz000003.jpg Edgar Link pending
gx5w3hu2llfz000004.jpg Edgar Link pending
gx5w3hu2llfz000005.jpg Edgar Link pending
gx5w3hu2llfz000006.jpg Edgar Link pending
gx5w3hu2llfz000007.jpg Edgar Link pending
gzltcykbovkp000001.jpg Edgar Link pending
life-10k_20151231.htm Edgar Link pending
life-20151231.xml Edgar Link completed
life-20151231.xsd Edgar Link pending
life-20151231_cal.xml Edgar Link unprocessable
life-20151231_def.xml Edgar Link unprocessable
life-20151231_lab.xml Edgar Link unprocessable
life-20151231_pre.xml Edgar Link unprocessable
life-ex1016_653.htm Edgar Link pending
life-ex1017_1072.htm Edgar Link pending
life-ex1018_655.htm Edgar Link pending
life-ex103_474.htm Edgar Link pending
life-ex231_12.htm Edgar Link pending
life-ex311_11.htm Edgar Link pending
life-ex312_10.htm Edgar Link pending
life-ex321_9.htm Edgar Link pending
life-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending